{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:51:55Z","timestamp":1786114315295,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.07.007","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:57:59Z","timestamp":1784577479000},"page":"4372-4373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding resistance in triple-negative breast cancer: NF-\u03baB as a therapeutic target for oncolytic virotherapy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-7089","authenticated-orcid":false,"given":"Afsar U.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.007_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2026.07.007_bib2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.007_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122684","article-title":"NF-\u03baB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges","volume":"348","author":"Guo","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2026.07.007_bib4","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.ymthe.2026.04.061","article-title":"Estrogen-mediated NF-\u03baB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy","volume":"34","author":"Viens","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.007_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.007_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1631\/jzus.B1900163","article-title":"Estrogen receptor coactivator Mediator Subunit 1 (MED1) as a tissue-specific therapeutic target in breast cancer","volume":"20","author":"Leonard","year":"2019","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.ymthe.2026.07.007_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.007_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114822","article-title":"The role of NF-\u03baB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy","volume":"163","author":"Pavitra","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2026.07.007_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101042","article-title":"Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancers","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ymthe.2026.07.007_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14728222.2023.2225767","article-title":"Modulating multidrug resistance to drug-based antitumor therapies through NF-\u03baB signaling pathway: mechanisms and perspectives","volume":"27","author":"Wu","year":"2023","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:44:59Z","timestamp":1785962699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626005757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1525001626005757"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding resistance in triple-negative breast cancer: NF-\u03baB as a therapeutic target for oncolytic virotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.061","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}